QUANTUM BIOCHEMISTRY OF INTERACTIONS AMONG COMPLEXES INVOLVED IN NEUROLOGICAL AND METABOLIC DISORDERS.
Depression, Alzheimer's disease, Biguanides, MFCC, DFT.
In our thesis, we investigated the quantum biochemistry of distinct complexes associated with: Alzheimer's disease (AD), a neurodegenerative disorder characterized by the presence of β-amyloid plaques (Aβ) and neurofibrillary tangles, resulting in progressive cognitive loss; depression, a highly prevalent psychiatric disorder with a significant functional impact, whose limitations in conventional treatments have driven interest in innovative therapies, including serotonergic psychedelics; and the action of biguanides on folate metabolism and nucleotide biosynthesis. These studies utilized advanced molecular modeling methodologies based on Density Functional Theory (DFT), employing the Molecular Fractionation with Conjugated Caps (MFCC) method, to investigate molecular interactions between ligands and their complexes. The individual energetic contributions of amino acid residues at the binding site were analyzed, enabling the identification of key residues that play fundamental roles in stabilizing and selecting protein-ligand complexes. The study shows that the strength and type of interaction are crucial for the stability and selectivity of ligands, regardless of the inhibitor's structure.